Introduction
Effect of bonding on solubility
Importance of Solubility
Types of Solutions
Factor affecting Solubility
Phase Solubility Analysis
Need for solubility enhancement
Technique for solubility enhancement
Reference
A co solvent system is one in which a water miscible or partially miscible organic solvent is mixed with water to form a modified aqueous solution. And the phenomenon called Cosolvency
cosolvents have some degree of hydrogen bond donating and or hydrogen bond accepting ability as well as small hydrocarbon regions.
The resulting solution will have physical properties that are intermediate to that of the pure organic solvent and water through the reduction of water–water interaction.
Phase solubility analysis and pH solubility profileMohit Angolkar
A Brief presentation on the topic- phase solubility analysis and pH solubility profile, which covers the following aspects:
- Solubility introduction
- importance of solubility
- factors influencing solubility
- Phase solubility analysis introduction
- method of analysis
- purification technique
- introduction to pH solubility profile.
Presentation include chapter solubility of drugs from second yr B-Pharm
Solubility, solubility expression, solute solvent interactions, solubility parameters, solvation and dissolution, factors affecting solubility, solubility of gases in liquids, liquids in liquids, fractional distillation, azeotropes, dissolution and drug release and diffusion.
A co solvent system is one in which a water miscible or partially miscible organic solvent is mixed with water to form a modified aqueous solution. And the phenomenon called Cosolvency
cosolvents have some degree of hydrogen bond donating and or hydrogen bond accepting ability as well as small hydrocarbon regions.
The resulting solution will have physical properties that are intermediate to that of the pure organic solvent and water through the reduction of water–water interaction.
Phase solubility analysis and pH solubility profileMohit Angolkar
A Brief presentation on the topic- phase solubility analysis and pH solubility profile, which covers the following aspects:
- Solubility introduction
- importance of solubility
- factors influencing solubility
- Phase solubility analysis introduction
- method of analysis
- purification technique
- introduction to pH solubility profile.
Presentation include chapter solubility of drugs from second yr B-Pharm
Solubility, solubility expression, solute solvent interactions, solubility parameters, solvation and dissolution, factors affecting solubility, solubility of gases in liquids, liquids in liquids, fractional distillation, azeotropes, dissolution and drug release and diffusion.
Standardization of Acids and bases.
2. Determination of pKa and pKb values
3. Preparation of solutions of different pH & buffer capacities.
4. Determination of phase diagram of binary systems.
5. Determination of distribution coefficients.
6. Determination of molecular weight by Victor Meyer’s Method.
7. Determination of heats of solutions by measuring solubility as a function of
temperature (Van’t Hoff equation.)
Sl. No. Date Name of the experiment Page No.
01 Conversion of different water insoluble or sparingly soluble substances into water soluble form. 01 – 07
02 Name of the Experiment: Manufacture of Aluminium Hydroxide Gel from the supplied material. 08 – 10
03-A Qualitative analysis (identification) of anions from inorganic salt solutions. 11 – 15
03-B Qualitative analysis (identification) of group I & group II cations. 16 – 20
03-C Qualitative analysis (identification) of group III cation. 21 – 27
03-D Qualitative analysis (identification) of group IV & group V cations. 28 – 31
Appendix 32
Safety Rules for chemistry laboratory 33
Physical Pharmacy-I lab + Data Sheet
1. Standardization of Acids and bases.
2. Determination of pKa and pKb values
3. Preparation of solutions of different pH & buffer capacities.
4. Determination of phase diagram of binary systems.
5. Determination of distribution coefficients.
6. Determination of molecular weight by Victor Meyer’s Method.
7. Determination of heats of solutions by measuring solubility as a function of
temperature (Van’t Hoff equation.)
Qualitative analysis of inorganic salts, Identification of anions and cations,Conversion of different water insoluble or sparingly soluble substances into water soluble form.
Name of the Experiment: Manufacture of Aluminium Hydroxide Gel from the supplied material.
Qualitative analysis (identification) of anions from inorganic salt solutions.
Qualitative analysis (identification) of group I & group II cations.
Qualitative analysis (identification) of group III cation.
Qualitative analysis (identification) of group IV & group V cations.
How to test the Ammonium with Litmus paper?
How to Clean a Platinum Wire?
What is Qualitative Analysis?
Dissolution apparatus, invivo-invitro corelation, factor affecting,BCS classification ..
Complete dissolution topic in this slide & easy way to write..
Cheak it now and give feedback
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...Kumar Satyam
According to the TechSci Research report titled “India Diagnostic Labs Market Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2019-2029,” the India Diagnostic Labs Market was valued at USD 16,471.21 million in 2023 and is projected to grow at an impressive compound annual growth rate (CAGR) of 11.55% through 2029. This significant growth can be attributed to various factors, including collaborations and partnerships among leading companies, the expansion of diagnostic chains, and increasing accessibility to diagnostic services across the country. This comprehensive report delves into the market dynamics, recent trends, drivers, competitive landscape, and benefits of the research report, providing a detailed analysis of the India Diagnostic Labs Market.
Collaborations and Partnerships
Collaborations and partnerships among leading companies play a pivotal role in driving the growth of the India Diagnostic Labs Market. These strategic alliances allow companies to merge their expertise, strengthen their market positions, and offer innovative solutions. By combining resources, companies can enhance their research and development capabilities, expand their product portfolios, and improve their distribution networks. These collaborations also facilitate the sharing of technological advancements and best practices, contributing to the overall growth of the market.
Expansion of Diagnostic Chains
The expansion of diagnostic chains is a driving force behind the growing demand for diagnostic lab services. Diagnostic chains often establish multiple laboratories and diagnostic centers in various cities and regions, including urban and rural areas. This expanded network makes diagnostic services more accessible to a larger portion of the population, addressing healthcare disparities and reaching underserved populations. The presence of diagnostic chain facilities in multiple locations within a city or region provides convenience for patients, reducing travel time and effort. A broader network of labs often leads to reduced waiting times for appointments and sample collection, ensuring that patients receive timely and efficient diagnostic services.
Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a significant driver for the demand for diagnostic lab services. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require regular monitoring and diagnostic testing for effective management. The rise in chronic diseases necessitates the use of advanced diagnostic tools and technologies, driving the growth of the diagnostic labs market. Additionally, early diagnosis and timely intervention are crucial for managing chronic diseases, further boosting the demand for diagnostic lab services.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
For those battling kidney disease and exploring treatment options, understanding when to consider a kidney transplant is crucial. This guide aims to provide valuable insights into the circumstances under which a kidney transplant at the renowned Hiranandani Hospital may be the most appropriate course of action. By addressing the key indicators and factors involved, we hope to empower patients and their families to make informed decisions about their kidney care journey.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
1. Prepared By: Dolly Sadrani
Department of Pharmaceutics
Ist Sem M.Pharma
1
2. Introduction
Effect of bonding on solubility
Importance of Solubility
Types of Solutions
Factor affecting Solubility
Phase Solubility Analysis
Need for solubility enhancement
Technique for solubility enhancement
Reference
2
3. Solubility
Qualitative term: Solubility is defined as, “the
spontaneous interactions of two or more substances to form a
homogeneous molecular dispersion”.
Quantitative term: Solubility is defined as, “the
concentration of a solute in a saturated solution at a constant
temperature”.
3
4. As Per USP and IP (2014)
4
Sr
no.
Descriptive Term Parts of Solvent
required For 1 Part
Of Solubility
1 Very Soluble < 1
2 Freely Soluble 1 to 10
3 Soluble 10 to 30
4 Sparingly Soluble 30 to 100
5 Slightly Soluble 100 to 1000
6 Very Slightly Soluble 1000 to 10,000
7 Practically insoluble > 10,000
5. As per IP 1996,
5
Sr
no.
Descriptive Term Approximate volume of
solvent in milliliters per
gram of solute
1 Very Soluble < 1
2 Freely Soluble 1 to 10
3 Soluble 10 to 30
4 Sparingly Soluble 30 to 100
5 Slightly Soluble 100 to 1000
6 Very Slightly Soluble 1000 to 10,000
7 Practically insoluble > 10,000
6. Solvent: Holes open in the solvent
Solute: Molecules of the solid break away from the bulk
Solution: The solid molecule is integrated into the hole in the
solvent
6
7. When the solute molecules are dispersed, the bonds or
attraction holding the particles are replaced by interactions
between solvent and solute.
Example Clofibrate is sparingly soluble in aqueous solvent
due to C-C bonds are much stronger than the possible
interaction between carbon atoms and water molecules.
When Clofibrate is dissolved in water a chemical reaction
must takes place in which multiple covalent bonds are broken.
By this we conclude that the stronger the interaction between
the solute particles, less favourable for the water solubility.
The stronger the interaction between solute and solvent
molecules, solubility will increases.
7
8. For Increasing the Bioavailability.
Achieve desired concentration of drug in systemic circulation.
Currently only 8 % of new drug candidates have both high
solubility and permeability.
Nearly 40% of the new chemical entities discovered as poorly
water soluble.
Selection of solvent for dosage form.
Selection of dosage form.
Information about the structure, Inter molecular forces.
Selection of dissolution medium.
Separation of mixtures.
8
9. Separation of optical isomers.
Detection of impurities.
Preparation of reference substances.
Determination of physicochemical properties.
9
10. Under saturated:
It is a state of a solution that contain less of a solute than could
be a dissolved by that quantity of solvent under normal
circumstances.
Saturated:
Solvent holds as much solute as is possible at that temperature.
Dissolved solute is in dynamic equilibrium with solid solute
particles.
Unsaturated:
Less than the amount of the solute for that temperature is
dissolved in the solvent.
Supersaturated:
Solvent holds more solute than is normally possible at that
temperature.
10
12. 1. The nature of the Solute and Solvent:
When two substances are similar they can dissolve in each
other.
Polar solute is dissolve in polar solvent.
Non polar solute is dissolve in non polar solvent.
“ LIKE DISSOLVES LIKE ”
Two liquids dissolve in each other because their molecule
are a like in polarity.
2. Temperature:
Raising the temperature will increases the solubility.
12
13. 3. Pressure:
When the pressure is increased over the solvent, the solubility
of the gas is increased.
Henry’s Law: “ Solubility of gas is directly proportional to
the partial pressure of the gas above the liquid.”
4. Surface area:
The greater the surface area per unit mass, the quicker it will
dissolve.
13
14. PSA is the quantitative determination of purity of a substance
through the application of precise solubility measurement.
variability of solubility indicates the presence of an impurity
or impurities.
Steps to determine the solubility:
Control temperature and pressure.
Add a quantity of solid to the solvent in the excess of what
will dissolve.
Let the system come to the equilibrium.
Use the specific assay to determine how much of the substance
(Concentration) in solution.
14
15. Solvent Selection:
Sufficient Volatility
Boiling point in between 60-150℃
Not react with test substance
Don’t form solvates, salt
Pure in nature
The test compound has solubility about 10-20mg/ml in the
solvents system.
15
16. Mixing, in series of separate systems, increasing quantities of
material and fixed amount of solvents
Establishment of equilibrium at identical constant temperature
and pressure
Separation of solid phase from solution
Determination of concentration of the material
Plotting the conc. Of the dissolved materials per unit of solvent
(Y) against the weight of material per unit of solvent (X)
16
18. Use the constant temperature bath that is capable of
maintaining the temperature within ±0.1 and that is equipped
with horizontal shaft capable of rotating at approximately 25
rpm.
The shaft is equipped with clamps to hold the ampoules.
The bath contain suitable vibrator, capable of agitating the
ampoules at 100 to 200 vibrations per second, and equipped
with the shaft and suitable clamps hold the ampoules.
Ampoules:
Use 15 ml ampoules.
Ampoules and Solubility flask used in phase solubility
analysis.
18
20. Mixing of material with Solvent.
Establishment of equilibrium.
Separation of solid phase from Solution.
Determination of concentration of material dissolved per unit
of Solvent.
Determination of weight of material unit of Solvent.
Plotting graph, Extrapolation and calculation.
20
21. Increased amount of Sample
+
5 ml Solvent
Cool in dry acetone Double jet air gas burner
Weigh all Ampoules
21
22. Calculate the system composition, in mg per g, for each
ampoules by the formula:
Csystem (mg/ml)= 1000×(W2 - W1) / (W3 – W2)
Where,
W1 = Weight of the ampoule plus test substance
W2 = Weight of the empty ampoule
W3 = Weight of the ampoule plus test substance, solvent
and separated glass
22
23. Equilibrium is obtained more rapidly by the vibration method
(1-7 days) than the rotational method (7-14 days).
Determine whether equilibration has been effected 1 ampoule,
the next to the last in the series
Warmed to 40 ℃ to produce a supersaturated solution.
Equilibration is ensured if the solubility obtained on the
supersaturated solution falls in line with the test specimens
that approach equilibrium from an under saturated solution.
23
25. System composition in mg/ gm for each ampoule:
1000(W2 - W1) / (W3 - W2)
Solution composition in mg/gm for each ampoule:
1000(F 3 –F1) / (F2 – F 3)
Where
F3: weight of the flask plus residue
F1: weight of the solubility flask
F2: weight of the flask plus solution
25
27. BC- Saturate with one component
CD- Saturate with 2 components
AE- Major Components
EF- Minor Components
27
28. Test Specimen + Non Reactive Solvent
So that about 10% of the material is dissolved at equilibrium.
Sealed and shaken at room temperature until equilibrium is
attained
Mother liquor is then drawn off and evaporated to dryness.
Mother liquor contained impurities that were present in the
specimen
The residue has been concentrated with respect to the
impurities roughly in proportion to the ratio of the weight of
specimen taken to the weight of solids dissolved in the volume
of solvent used.
The undissolved crystals remaining after withdrawal of the
mother liquor are usually sufficiently pure to be used as a
reference standard after appropriate rinsing and drying.
28
29. There are variety of new drugs and derivatives are available.
But less than 40% of lipophilic drugs candidates fail to reach
market due to poor bioavailability, even these drugs might
exhibit pharmacodynamic activities.
The lipophilic drugs that reaches market requires a high dose
to attain proper pharmacological action.
29
30. 1. Physical Modification
A. Particle Size reduction
- Micronization
- Sonocrystalisation
- Nanosuspension
- Supercritical Fluid Process
B. Modification of crystal habits
- Polymorphs
- Pseudopolymorphs
C. Drug Dispersion Carriers
- Eutectic Mixture
- Solid Dispersion
D. Lyophilisation
30
31. 2. Chemical Modification
- Change in pH
- Complexation
- Salt formation
3. Other Method
- Co Crystallisation
- Co Solvency
- Solubilizing agent
- Solvent disposition
- Selective Adsorption on insoluble carriers
- Using Soluble Prodrug
31
32. Particle Size reduction can be achieved by:
Micronization:
Micronization increases the dissolution rate of drug through
increased surface area.
Example: Fenofibrate
Nanosuspension:
It is a biphasic system consist of nano size drug particles
stabilized by surfactant for either oral and topical use or
parenteral and pulmonary administration.
Example: Azithromycin
32
33. Sonocrysallisation:
In these utilization of ultrasound power for introducing
crystallisation.
Example: Rosiglitazone
Super Critical Fluid Process:
A SCF can be define as, “ dense non condensable fluid.”
B. Modification of crystal habit:
Polymorphs:
Polymorphs exist in 2 form
(I) Stable form: Shows low aqueous solubility.
(II) Metastable form: Shows high aqueous Solubility.
Example: Polymorphic form III of riboflavin is 20 times more
water soluble than form I.
33
34. Pseudopolymorphs: (Hydrates & Solvates)
The anhydrous form of drug has greater aqueous solubility
than the hydrates, because of the hydrates are already in
interaction with water and therefore have less energy for
crystal breakup in comparison to the anhydrous for further
interaction with water.
Example: Chloroform solvates of griseofulvin more water
soluble than their non solvates form.
C. Drug dispersion:
Eutectic mixture:
When these mixture is exposed to water the soluble carrier
dissolves leaving the drug in a microcrystalline state which
solubilize rapidly.
34
35. Example: Mixture of paracetamol and Urea
Solid dispersion:
Prepared by solvent or co precipitation method.
Guest solute + solid carrier solvent
Dissolved in common volatile liquid solvent (Alcohol)
The liquid solvent is removed by evaporation under reduced
pressure or by freeze drying which results in amorphous
precipitation of guest in crystalline carrier which solubilizes
rapidly.
Example: Amorphous sulfathiazole in crystalline urea.
35
36. Amorphous powder with high degree of interaction between
drug and carrier like cyclodextrine.
It get in to porous – solubilizes rapidly.
Example: Indomethacin having low solubility in water
increased by lyophilisation.
Change of pH:
This can be achieved in two ways
(I) In situ salt formation
(II) Addition of buffers to formulation
Example: Buffered Aspirin tablet.
36
37. Complexation:
The beta and gamma cyclodextrin having ability to form
molecular inclusion complexes with hydrophilic drug having
poor aqueous solubility.
Example: Barbiturates , Benzodiazepines.
Salt formation:
Salts have improve solubility in comparison to the original
drug.
Example,: -Alkali metal salts of acidic drug like penicillin
-Strong acid salt of basic drug like atropine are water
soluble than parent drugs.
37
38. Co crystallization:
It is a define as “ a crystalline material that consist of two or
more molecular species held together by non covalent bond.
Co solvency:
The solubilization of drug in co solvent.
Solubilizing agent:
Adding various solubilizing material.
Solvent disposition:
In that poorly water soluble drugs like nifedipine is dissolved
in an organic solvent like Alcohol and deposited on an inert,
hydrophilic, solid matrix such as starch or MCC and
evaporation of solvent is done.
38
39. Selective adsorption on insoluble carriers:
A highly active adsorbent like inorganic clays, bentonite can
enhance the dissolution rate by maintaining the concentration
gradient at its maximum.
Use of soluble prodrug:
It involves incorporation of polar or ionizable moiety into the
parent compound to improve water solubility of
corticosteroids, Benzodiazepines.
39
40. 1. International journal of pharma professional’s research review
solubility enhancement techniques volume 1, issue 1, July
2010.
2. Journal of Global Pharma Technology Techniques To
Solubility of poorly Soluble Drugs Review.
3. The International Pharmacopoeia Eight edition, 2018.
4. The United States Pharmacopeia Volume III.
5. Remington The science and practice of pharmacy 19th edition
Page no. 194-200.
6. World research journal of pharmaceutical Research volume 1,
issue 1, 2013.
40
41. 7. International journal of pharma professional’s research review
article solubility enhancement techniques volume 1, issue 1,
July 2010.
8. https://www.researchgate.net/publication/325686980
9. Journal of pharmaceutical Sciences volume61, issue 7, July
1972, Page no 1069-1075.
10. Phase solubility analysis William J. Madar & Takeru Higuchi
Pages 193- 215 Published online 18 Feb 2008.
11. https://chem.libretexts.org
12. Ansel Book of Pharmaceutics Page no. 214
41